Prostate cancer Trials in Herston, Australia
Conditions / Prostate cancer / Herston, Australia
Prostate cancer is a medical condition with active clinical research programs worldwide.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06780670 | Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy | RECRUITING | — |
| NCT05150236 | EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC | UNKNOWN | PHASE2 |
| NCT06970847 | 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer | RECRUITING | PHASE3 |
| NCT03151629 | International Registry for Men With Advanced Prostate Cancer (IRONMAN) | RECRUITING | — |
| NCT01212991 | A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer | COMPLETED | PHASE3 |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | COMPLETED | PHASE3 |
| NCT01308567 | Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT00887198 | Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer | COMPLETED | PHASE3 |
| NCT04136353 | Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00925600 | Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss | COMPLETED | PHASE3 |